Yale Cancer Center Site #109 — New Haven, Connecticut

Yale Cancer Center Site #109 is a clinical research site located in New Haven, Connecticut, United States 06511.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Yale Cancer Center Site #109 has participated in 1 clinical trials.

Therapeutic areas: Relapsed/Refractory Peripheral T-cell Lymphoma.

Sponsors: Taiho Oncology, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Haven

Browse all research sites in Connecticut · View every site in New Haven

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale Cancer Center Site #109?

Yale Cancer Center Site #109 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale Cancer Center Site #109 conducted?

Yale Cancer Center Site #109 has 1 clinical trials on record. Their work covers Relapsed/Refractory Peripheral T-cell Lymphoma.

Is Yale Cancer Center Site #109 accredited by Crixeo Clinical Trials?

Yale Cancer Center Site #109 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale Cancer Center Site #109?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.